Long-term outcomes of endoscopic resection of dysplasia in patients with Inflammatory Bowel Disease
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S395
DOI: 10.1055/s-0044-1783679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von J. Fricker und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Aims
The technical feasibility of endoscopic resection (ER) in inflammatory bowel disease (IBD) has previously been reported [ 1 ], however these studies are limited by the lack of long-term outcomes for patients. This study therefore aims to evaluate the long-term outcomes of patients with IBD undergoing ER for visible neoplasia.
Methods
A prospective database was maintained of all IBD patients who had undergone ER for visible neoplasia. The database was interrogated for pre-defined outcome measures.
Results
36 IBD patients who had undergone ER for neoplasia at a single centre had follow-up data available. 20 patients were male. Median age was 66 (30-86). 81% (n=29) had ulcerative colitis and 20% (n=7) had Crohns Colitis. 3 patients had a co-existing Primary Sclerosing Cholangitis (PSC). Resection was performed by knife assisted resection (KAR) in 47% (n=17), endoscopic submucosal dissection (ESD) in 39% (n=14) and endoscopic mucosal resection (EMR) in 11% (n=4) of patients. The overall mean follow-up from the time of ER was 48 months (range 0–167). 31 patients entered endoscopic surveillance and mean follow up time of this group was 51 months (5-167). Of these 18.2% (n=6) developed metachronous lesions requiring further ER. 4/6 of these had curative endoscopic resection. 22% (n=8) of patients went on to have surgery. Indications included poor prognostic markers after ER (n=5), unsuccessful medical management of IBD (n=2) and post endoscopy complications (n=1). The median time between ER and need for surgery was 5 months (0-141). 7 patients died of which only 1 was related to their IBD. 3 patients were lost to follow-up.
Conclusions
IBD patients are at high risk of developing metachronous neoplasia so should be meticulously followed up with endoscopic surveillance. Metachronous lesions can be detected and resected endoscopically. 20% of patients go on to have surgery following ER, the majority of these are due to poor prognostic markers following ER. No patients died due to advanced cancer following ER. This study provides important information for counselling patients on management options for visible neoplasia in IBD. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Fricker, J., Siggens, K., Htet, H., Thayalasekaran, S., Alkandari, A., & Pradeep, B. (2024). Long-term outcomes of endoscopic resection of dysplasia in patients with Inflammatory Bowel Disease. Endoscopy, 56(S 02 S 02), S395. https://doi.org/10.1055/s-0044-1783679
Vancouver
Fricker J, Siggens K, Htet H, Thayalasekaran S, Alkandari A, Pradeep B. Long-term outcomes of endoscopic resection of dysplasia in patients with Inflammatory Bowel Disease. Endoscopy. 2024;56(S 02 S 02):S395. doi:10.1055/s-0044-1783679
BibTeX
@article{Fricker2024,
author = {Fricker, J. and Siggens, K. and Htet, H. and Thayalasekaran, S. and Alkandari, A. and Pradeep, B.},
title = {Long-term outcomes of endoscopic resection of dysplasia in patients with Inflammatory Bowel Disease},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S395},
doi = {10.1055/s-0044-1783679}
}
EUVIMED